{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T23:17:35Z","timestamp":1788218255609,"version":"build-2803163510"},"reference-count":41,"publisher":"Japanese Circulation Society","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Circ J"],"published-print":{"date-parts":[[2016]]},"DOI":"10.1253\/circj.cj-16-0152","type":"journal-article","created":{"date-parts":[[2016,6,30]],"date-time":"2016-06-30T19:09:21Z","timestamp":1467313761000},"page":"1988-1997","source":"Crossref","is-referenced-by-count":50,"title":["Suppressive Effects of Glucose-Dependent Insulinotropic Polypeptide on Cardiac Hypertrophy and Fibrosis in Angiotensin II-Infused Mouse Models"],"prefix":"10.1253","volume":"80","author":[{"given":"Munenori","family":"Hiromura","sequence":"first","affiliation":[{"name":"Department of Medicine, Division of Diabetes, Metabolism and Endocrinology, Showa University School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yusaku","family":"Mori","sequence":"additional","affiliation":[{"name":"Department of Medicine, Division of Diabetes, Metabolism and Endocrinology, Showa University School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyoko","family":"Kohashi","sequence":"additional","affiliation":[{"name":"Department of Medicine, Division of Diabetes, Metabolism and Endocrinology, Showa University School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michishige","family":"Terasaki","sequence":"additional","affiliation":[{"name":"Department of Medicine, Division of Diabetes, Metabolism and Endocrinology, Showa University School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyoko","family":"Shinmura","sequence":"additional","affiliation":[{"name":"Department of Medicine, Division of Diabetes, Metabolism and Endocrinology, Showa University School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takaharu","family":"Negoro","sequence":"additional","affiliation":[{"name":"Department of Pharmacogenomics, Showa University School of Pharmacy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hikaru","family":"Kawashima","sequence":"additional","affiliation":[{"name":"Laboratory of Cardiovascular Medicine, Tokyo University of Pharmacy and Life Sciences"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mao","family":"Kogure","sequence":"additional","affiliation":[{"name":"Laboratory of Cardiovascular Medicine, Tokyo University of Pharmacy and Life Sciences"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshimi","family":"Wachi","sequence":"additional","affiliation":[{"name":"Laboratory of Cardiovascular Medicine, Tokyo University of Pharmacy and Life Sciences"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rena","family":"Watanabe","sequence":"additional","affiliation":[{"name":"Laboratory of Cardiovascular Medicine, Tokyo University of Pharmacy and Life Sciences"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kengo","family":"Sato","sequence":"additional","affiliation":[{"name":"Laboratory of Cardiovascular Medicine, Tokyo University of Pharmacy and Life Sciences"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideki","family":"Kushima","sequence":"additional","affiliation":[{"name":"Department of Medicine, Division of Diabetes, Metabolism and Endocrinology, Showa University School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masako","family":"Tomoyasu","sequence":"additional","affiliation":[{"name":"Department of Medicine, Division of Diabetes, Metabolism and Endocrinology, Showa University School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuko","family":"Nakano","sequence":"additional","affiliation":[{"name":"Department of Pharmacogenomics, Showa University School of Pharmacy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuichiro","family":"Yamada","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Diabetes and Geriatric Medicine, Akita University Graduate School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takuya","family":"Watanabe","sequence":"additional","affiliation":[{"name":"Laboratory of Cardiovascular Medicine, Tokyo University of Pharmacy and Life Sciences"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsutomu","family":"Hirano","sequence":"additional","affiliation":[{"name":"Department of Medicine, Division of Diabetes, Metabolism and Endocrinology, Showa University School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"330","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Drucker DJ. The biology of incretin hormones. <i>Cell Metab<\/i> 2006; 3: 153\u2013165.","DOI":"10.1016\/j.cmet.2006.01.004"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Nagashima M, Watanabe T, Terasaki M, Tomoyasu M, Nohtomi K, Kim-Kaneyama J, et al. Native incretins prevent the development of atherosclerotic lesions in apolipoprotein E knockout mice. <i>Diabetologia<\/i> 2011; 54: 2649\u20132659.","DOI":"10.1007\/s00125-011-2241-2"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Usdin TB, Mezey E, Button DC, Brownstein MJ, Bonner TI. Gastric inhibitory polypeptide receptor, a member of the secretin-vasoactive intestinal peptide receptor family, is widely distributed in peripheral organs and the brain. <i>Endocrinology<\/i> 1993; 133: 2861\u20132870.","DOI":"10.1210\/endo.133.6.8243312"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Osadchii OE. Cardiac hypertrophy induced by sustained beta-adrenoreceptor activation: Pathophysiological aspects. <i>Heart Fail Rev<\/i> 2007; 12: 66\u201386.","DOI":"10.1007\/s10741-007-9007-4"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Zoccarato A, Surdo NC, Aronsen JM, Fields LA, Mancuso L, Dodoni G, et al. Cardiac hypertrophy is inhibited by a local pool of cAMP regulated by phosphodiesterase 2. <i>Circ Res<\/i> 2015; 117: 707\u2013719.","DOI":"10.1161\/CIRCRESAHA.114.305892"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Hayes JS, Brunton LL, Brown JH, Reese JB, Mayer SE. Hormonally specific expression of cardiac protein kinase activity. <i>Proc Natl Acad Sci USA<\/i> 1979; 76: 1570\u20131574.","DOI":"10.1073\/pnas.76.4.1570"},{"key":"7","unstructured":"7. Hayes JS, Brunton LL. Functional compartments in cyclic nucleotide action. <i>J Cyclic Nucleotide Res<\/i> 1982; 8: 1\u201316."},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Goo\u00dfen K, Gr\u00e4ber S. Longer term safety of dipeptidyl peptidase-4 inhibitors in patients with type 2 diabetes mellitus: Systematic review and meta-analysis. <i>Diabetes Obes Metab<\/i> 2012; 14: 1061\u20131072.","DOI":"10.1111\/j.1463-1326.2012.01610.x"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Scirica BM, Bhatt DL, Braunwald E, Steg PG, Davidson J, Hirshberg B, et al. Saxagliptin and cardiovascular outcomes in patients with type 2 diabetes mellitus. <i>N Engl J Med<\/i> 2013; 369: 1317\u20131326.","DOI":"10.1056\/NEJMoa1307684"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Green JB, Bethel MA, Armstrong PW, Buse JB, Engel SS, Garg J, et al. Effect of sitagliptin on cardiovascular outcomes in type 2 diabetes. <i>N Engl J Med<\/i> 2015; 373: 232\u2013242.","DOI":"10.1056\/NEJMoa1501352"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Sundstrom J, Lind L, Vessby B, Andren B, Aro A, Lithell H. Dyslipidemia and an unfavorable fatty acid profile predict left ventricular hypertrophy 20 years later. <i>Circulation<\/i> 2001; 103: 836\u2013841.","DOI":"10.1161\/01.CIR.103.6.836"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Tashiro Y, Sato K, Watanabe T, Nohtomi K, Terasaki M, Nagashima M, et al. A glucagon-like peptide-1 analog liraglutide suppresses macrophage foam cell formation and atherosclerosis. <i>Peptides<\/i> 2014; 54: 19\u201326.","DOI":"10.1016\/j.peptides.2013.12.015"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Miyawaki K, Yamada Y, Yano H, Niwa H, Ban N, Ihara Y, et al. Glucose intolerance caused by a defect in the entero-insular axis: A study in gastric inhibitory polypeptide receptor knockout mice. <i>Proc Natl Acad Sci USA<\/i> 1999; 96: 14843\u201314847.","DOI":"10.1073\/pnas.96.26.14843"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Kohashi K, Hiromura M, Mori Y, Terasaki M, Watanabe T, Kushima H, et al. A dipeptidyl peptidase-4 inhibitor but not incretins suppresses abdominal aortic aneurysms in angiotensin II-infused apolipoprotein E-null mice. <i>J Atheroscler Thromb<\/i> 2016; 23: 441\u2013454.","DOI":"10.5551\/jat.31997"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Kim M, Platt MJ, Shibasaki T, Quaggin SE, Backx PH, Seino S, et al. GLP-1 receptor activation and Epac2 link atrial natriuretic peptide secretion to control of blood pressure. <i>Nat Med<\/i> 2013; 19: 567\u2013575.","DOI":"10.1038\/nm.3128"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Maisel A. B-type natriuretic peptide levels: A potential novel \u201cwhite count\u201d for congestive heart failure. <i>J Card Fail<\/i> 2001; 7: 183\u2013193.","DOI":"10.1054\/jcaf.2001.24609"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Porrello ER, Mahmoud AI, Simpson E, Hill JA, Richardson JA, Olson EN, et al. Transient regenerative potential of the neonatal mouse heart. <i>Science<\/i> 2011; 331: 1078\u20131080.","DOI":"10.1126\/science.1200708"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Wu J, You J, Wang S, Zhang L, Gong H, Zou Y. Insights into the activation and inhibition of angiotensin II type 1 receptor in the mechanically loaded heart. <i>Circ J<\/i> 2014; 78: 1283\u20131289.","DOI":"10.1253\/circj.CJ-14-0470"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Rosenkranz S, Flesch M, Amann K, Haeuseler C, Kilter H, Seeland U, et al. Alterations of beta-adrenergic signaling and cardiac hypertrophy in transgenic mice overexpressing TGF-beta(1). <i>Am J Physiol Heart Circ Physiol<\/i> 2002; 283: H1253\u2013H1262.","DOI":"10.1152\/ajpheart.00578.2001"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Kim S, Ohta K, Hamaguchi A, Yukimura T, Miura K, Iwao H. Effects of an AT1 receptor antagonist, an ACE inhibitor and a calcium channel antagonist on cardiac gene expressions in hypertensive rats. <i>Br J Pharmacol<\/i> 1996; 118: 549\u2013556.","DOI":"10.1111\/j.1476-5381.1996.tb15437.x"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Parker TG, Packer SE, Schneider MD. Peptide growth factors can provoke \u201cfetal\u201d contractile protein gene expression in rat cardiac myocytes. <i>J Clin Invest<\/i> 1990; 85: 507\u2013514.","DOI":"10.1172\/JCI114466"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Schultz Jel J, Witt SA, Glascock BJ, Nieman ML, Reiser PJ, Nix SL, et al. TGF-beta1 mediates the hypertrophic cardiomyocyte growth induced by angiotensin II. <i>J Clin Invest<\/i> 2002; 109: 787\u2013796.","DOI":"10.1172\/JCI0214190"},{"key":"23","unstructured":"23. Mauviel A. Transforming growth factor-beta: A key mediator of fibrosis. <i>Methods Mol Med<\/i> 2005; 117: 69\u201380."},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Yuan Y, Zong J, Zhou H, Bian ZY, Deng W, Dai J, et al. Puerarin attenuates pressure overload-induced cardiac hypertrophy. <i>J Cardiol<\/i> 2014; 63: 73\u201381.","DOI":"10.1016\/j.jjcc.2013.06.008"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Wenzel S, Taimor G, Piper HM, Schl\u00fcter KD. Redox-sensitive intermediates mediate angiotensin II-induced p38 MAP kinase activation, AP-1 binding activity, and TGF-\u03b2 expression in adult ventricular cardiomyocytes. <i>FASEB J<\/i> 2001; 15: 2291\u20132293.","DOI":"10.1096\/fj.00-0827fje"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Balteau M, Van Steenbergen A, Timmermans AD, Dessy C, Behets-Wydemans G, Tajeddine N, et al. AMPK activation by glucagon-like peptide-1 prevents NADPH oxidase activation induced by hyperglycemia in adult cardiomyocytes. <i>Am J Physiol Heart Circ Physiol<\/i> 2014; 307: H1120\u2013H1133.","DOI":"10.1152\/ajpheart.00210.2014"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. Widenmaier SB, Ao Z, Kim SJ, Warnock G, McIntosh CH. Suppression of p38 MAPK and JNK via Akt-mediated inhibition of apoptosis signal-regulating kinase 1 constitutes a core component of the beta-cell pro-survival effects of glucose-dependent insulinotropic polypeptide. <i>J Biol Chem<\/i> 2009; 284: 30372\u201330382.","DOI":"10.1074\/jbc.M109.060178"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28. Schneiders D, Heger J, Best P, Michael Piper H, Taimor G. SMAD proteins are involved in apoptosis induction in ventricular cardiomyocytes. <i>Cardiovasc Res<\/i> 2005; 67: 87\u201396.","DOI":"10.1016\/j.cardiores.2005.02.021"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29. McMullen JR, Shioi T, Zhang L, Tarnavski O, Sherwood MC, Kang PM, et al. Phosphoinositide 3-kinase (p110alpha) plays a critical role for the induction of physiological, but not pathological, cardiac hypertrophy. <i>Proc Natl Acad Sci USA<\/i> 2003; 100: 12355\u201312360.","DOI":"10.1073\/pnas.1934654100"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30. Lin Z, Zhou P, von Gise A, Gu F, Ma Q, Chen J, et al. Pi3kcb links Hippo-YAP and PI3K-AKT signaling pathways to promote cardiomyocyte proliferation and survival. <i>Circ Res<\/i> 2015; 116: 35\u201345.","DOI":"10.1161\/CIRCRESAHA.115.304457"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31. Conery AR, Cao Y, Thompson EA, Townsend CM Jr, Ko TC, Luo K. Akt interacts directly with Smad3 to regulate the sensitivity to TGF-beta induced apoptosis. <i>Nat Cell Biol<\/i> 2004; 6: 366\u2013372.","DOI":"10.1038\/ncb1117"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32. Lamouille S, Derynck R. Cell size and invasion in TGF-beta-induced epithelial to mesenchymal transition is regulated by activation of the mTOR pathway. <i>J Cell Biol<\/i> 2007; 178: 437\u2013451.","DOI":"10.1083\/jcb.200611146"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33. Stuenaes JT, Bolling A, Ingvaldsen A, Rommundstad C, Sudar E, Lin FC, et al. Beta-adrenoceptor stimulation potentiates insulin-stimulated PKB phosphorylation in rat cardiomyocytes via cAMP and PKA. <i>Br J Pharmacol<\/i> 2010; 160: 116\u2013129.","DOI":"10.1111\/j.1476-5381.2010.00677.x"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34. Zag\u00f3rska A, Dulak J. HIF-1: The knowns and unknowns of hypoxia sensing. <i>Acta Biochim Pol<\/i> 2004; 51: 563\u2013585.","DOI":"10.18388\/abp.2004_3545"},{"key":"35","doi-asserted-by":"crossref","unstructured":"35. H\u00f6lscher M, Sch\u00e4fer K, Krull S, Farhat K, Hesse A, Silter M, et al. Unfavourable consequences of chronic cardiac HIF-1\u03b1 stabilization. <i>Cardiovasc Res<\/i> 2012; 94: 77\u201386.","DOI":"10.1093\/cvr\/cvs014"},{"key":"36","doi-asserted-by":"crossref","unstructured":"36. Ebert BL, Firth JD, Ratcliffe PJ. Hypoxia and mitochondrial inhibitors regulate expression of glucose transporter-1 via distinct Cis-acting sequences. <i>J Biol Chem<\/i> 1995; 270: 29083\u201329089.","DOI":"10.1074\/jbc.270.49.29083"},{"key":"37","doi-asserted-by":"crossref","unstructured":"37. Wice BM, Reeds DN, Tran HD, Crimmins DL, Patterson BW, Dunai J, et al. Xenin-25 amplifies GIP-mediated insulin secretion in humans with normal and impaired glucose tolerance but not type 2 diabetes. <i>Diabetes<\/i> 2012; 61: 1793\u20131800.","DOI":"10.2337\/db11-1451"},{"key":"38","doi-asserted-by":"crossref","unstructured":"38. Amland PF, Jorde R, Aanderud S, Burhol PG, Giercksky KE. Effects of intravenously infused porcine GIP on serum insulin, plasma C-peptide, and pancreatic polypeptide in non-insulin-dependent diabetes in the fasting state. <i>Scand J Gastroenterol<\/i> 1985; 20: 315\u2013320.","DOI":"10.3109\/00365528509091657"},{"key":"39","doi-asserted-by":"crossref","unstructured":"39. Svensson AM, Efendic S, Ostenson CG, Jansson L. Gastric inhibitory polypeptide and splanchnic blood perfusion: Augmentation of the islet blood flow increase in hyperglycemic rats. <i>Peptides<\/i> 1997; 18: 1055\u20131059.","DOI":"10.1016\/S0196-9781(97)00031-4"},{"key":"40","doi-asserted-by":"crossref","unstructured":"40. Sauer B. Functional expression of the cre-lox site-specific recombination system in the yeast Saccharomyces cerevisiae. <i>Mol Cell Biol<\/i> 1987; 7: 2087\u20132096.","DOI":"10.1128\/MCB.7.6.2087"},{"key":"41","doi-asserted-by":"crossref","unstructured":"41. Gossen M, Bujard H. Tight control of gene expression in mammalian cells by tetracycline-responsive promoters. <i>Proc Natl Acad Sci USA<\/i> 1992; 89: 5547\u20135551.","DOI":"10.1073\/pnas.89.12.5547"}],"container-title":["Circulation Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/circj\/80\/9\/80_CJ-16-0152\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,23]],"date-time":"2020-09-23T01:04:27Z","timestamp":1600823067000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/circj\/80\/9\/80_CJ-16-0152\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016]]},"references-count":41,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2016]]}},"URL":"https:\/\/doi.org\/10.1253\/circj.cj-16-0152","relation":{},"ISSN":["1346-9843","1347-4820"],"issn-type":[{"value":"1346-9843","type":"print"},{"value":"1347-4820","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016]]}}}